Testing effectiveness (Phase 2)Active Not RecruitingNCT04668885
What this trial is testing
CPX-351 as a Novel Approach for the Treatment of Older Patients With AML and MDS
Who this might be right for
Refractory Acute Myeloid LeukemiaRelapsed Acute Myelomonocytic LeukemiaMyelodysplastic Syndromes
Case Comprehensive Cancer Center 13